Enbrel has been a boon in the treatment of various inflammatory arthritis conditions. It is a medication from the class of ‘biological modifiers’….medications that alter the dynamics of inflammation through specific, scientifically determined immune pathways.
Expensive (several thousands of dollars per year) and available only injection form, it has been highly successful in providing symptom relief and disease modification in:
Rheumatoid Arthritis
Juvenil Arthritis
Psoriasis with Severe plaque formation on the skin
Ankylosing Spondylitis
Now, it may be available soon in a pill form, at a substantial cost savings.
No specific information is available, but I have it from good sources that Pfizer, who owns the medication, is planning on a ‘roll out’ campaign soon.